3697-68-5

Basic information

• Product Name: 1-HYDROXYMETHYL-CYCLOPROPANECARBOXYLIC ACID ETHYL ESTER
• Synonyms: 1-HYDROXYMETHYL-CYCLOPROPANECARBOXYLIC ACID ETHYL ESTER;Cyclopropanecarboxylic acid, 1-(hydroxyMethyl)-, ethyl ester;Ethyl 1-(hydroxyMethyl)cyclopropanecarboxylate, 97%;ethyl 1-(hydroxymethyl)cyclopropane-1-carboxylate;Ethyl 1-(hydroxymethyl);1,1 Cyclopropane dicarboxylic acid ethyl ester
• CAS NO: 3697-68-5
• Molecular Formula: C₇H₁₂O₃
• Molecular Weight: 144.17
• Mol File: 3697-68-5.mol
• Article Data: 18

Chemical Properties

• Boiling Point: 90-94 °C(Press: 8 Torr)
• Appearance: /
• Density: 1.159±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 15.10±0.10(Predicted)
• CAS DataBase Reference: 1-HYDROXYMETHYL-CYCLOPROPANECARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 1-HYDROXYMETHYL-CYCLOPROPANECARBOXYLIC ACID ETHYL ESTER(3697-68-5)
• EPA Substance Registry System: 1-HYDROXYMETHYL-CYCLOPROPANECARBOXYLIC ACID ETHYL ESTER(3697-68-5)

Safety Data

• Hazardous Substances Data: 3697-68-5(Hazardous Substances Data)

Usage

Uses

Ethyl 1-(hydroxymethyl)cyclopropanecarboxylate acts as a ligand for Suzuki coupling reaction.

Upstream product

• 3697-66-3 1,1-cyclopropanedicarboxylic acid monoethyl ester 
• 108-23-6 isopropyl chloroformate 
• 105-53-3 diethyl malonate 
• 1559-02-0 diethyl cyclopropane-1,1-dicarboxylate 

Downstream Products

• 1262141-53-6 C₂₁H₃₅N₃O₅ 
• 3697-70-9 4-oxo-5-azaspiro<2.4>heptane 
• 1823918-74-6 ethyl 1-(bromomethyl)cyclopropanecarboxylate 
• 4845-11-8 ethyl 1-({[(4-methylphenyl)sulfonyl]oxy}methyl)cyclopropanecarboxylate 

Relevant articles and documents

ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS

The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

This document discloses molecules having the following formula (“Formula One”): and processes related thereto.

TRI-HETEROCYCLIC DERIVATIVES, PREPARATION PROCESS AND USES THEREOF

The present invention relates to a tri-heterocyclic derivatives, preparation process and uses thereof, specifically relates to a tri-heterocyclic derivatives of the formula (I) or a pharmaceutically acceptable salt thereof, preparation process, and further relates to a pharmaceutically acceptable composition comprising compounds of formula (I), or a pharmaceutically acceptable salt thereof, and their pharmaceutical use as inhibitors of kinase